NIH-funded research R01 grant

Understanding how fat metabolism affects T cell aging and immune response in cancer

Official title: Excessive lipid metabolism in T cell senescence and immunosuppression

Funded at Washington University · NIH-10898921 · Data updated 2026-11-12

This study is looking at how too much fat processing in the body affects the aging and performance of immune cells called T cells, especially in cancer patients, to find ways to boost their ability to fight tumors.

More Immunosuppression research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startAugust 3, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$388,750
NIH project number5R01AI173260-02
Project IDNIH-10898921 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are cancer patients, particularly those with tumors that exhibit T cell dysfunction.

Less likely to help

Patients with non-cancerous conditions or those whose tumors do not involve T cell suppression may not benefit from this research.

What this research studies

This research investigates how excessive lipid metabolism contributes to the aging and dysfunction of T cells, particularly in the context of cancer. By examining the tumor microenvironment, the study aims to uncover the mechanisms that lead to T cell senescence, which impairs the immune response against tumors. The approach involves analyzing tumor-infiltrating T cells from cancer patients to identify specific molecular changes associated with T cell dysfunction. This knowledge could pave the way for new immunotherapy strategies that enhance T cell activity in cancer treatment.

Why it matters

Potential benefit: If successful, this research could lead to improved immunotherapy options that better activate T cells to fight cancer.

How similar studies have gone: Other research has shown promise in understanding T cell dysfunction in cancer, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Peng, Guangyong — Washington University
  • Study coordinator: Peng, Guangyong

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.